Skip to main content
. 2022 Jun 25;35(10):1475–1483. doi: 10.1038/s41379-022-01102-x

Fig. 4. Histopathological and molecular characteristics of all high-risk endometrial cancers (n = 128) with abnormal p53 immunohistochemistry and/or a pathogenic TP53 mutation.

Fig. 4

IHC immunohistochemistry, G grade, MMRd mismatch repair deficient, NSMP no specific molecular profile; p53abn, p53-abnormal.